BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 25996136)

  • 1. Lineage Tracing Using Cux2-Cre and Cux2-CreERT2 Mice.
    Gil-Sanz C; Espinosa A; Fregoso SP; Bluske KK; Cunningham CL; Martinez-Garay I; Zeng H; Franco SJ; Müller U
    Neuron; 2015 May; 86(4):1091-1099. PubMed ID: 25996136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cux2-positive radial glial cells generate diverse subtypes of neocortical projection neurons and macroglia.
    Eckler MJ; Nguyen TD; McKenna WL; Fastow BL; Guo C; Rubenstein JLR; Chen B
    Neuron; 2015 May; 86(4):1100-1108. PubMed ID: 25996137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fezf2 expression identifies a multipotent progenitor for neocortical projection neurons, astrocytes, and oligodendrocytes.
    Guo C; Eckler MJ; McKenna WL; McKinsey GL; Rubenstein JL; Chen B
    Neuron; 2013 Dec; 80(5):1167-74. PubMed ID: 24314728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamics of Cux2 expression suggests that an early pool of SVZ precursors is fated to become upper cortical layer neurons.
    Zimmer C; Tiveron MC; Bodmer R; Cremer H
    Cereb Cortex; 2004 Dec; 14(12):1408-20. PubMed ID: 15238450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A powerful transgenic tool for fate mapping and functional analysis of newly generated neurons.
    Zhang J; Giesert F; Kloos K; Vogt Weisenhorn DM; Aigner L; Wurst W; Couillard-Despres S
    BMC Neurosci; 2010 Dec; 11():158. PubMed ID: 21194452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cux2 serves as a novel lineage marker of granule cell layer neurons from the rhombic lip in mouse and chick embryos.
    Capaldo E; Iulianella A
    Dev Dyn; 2016 Aug; 245(8):881-96. PubMed ID: 27198720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lmx1a drives Cux2 expression in the cortical hem through activation of a conserved intronic enhancer.
    Fregoso SP; Dwyer BE; Franco SJ
    Development; 2019 Mar; 146(5):. PubMed ID: 30770393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PRISM: A Progenitor-Restricted Intersectional Fate Mapping Approach Redefines Forebrain Lineages.
    Poulin JF; Luppi MP; Hofer C; Caronia G; Hsu PK; Chan CS; Awatramani R
    Dev Cell; 2020 Jun; 53(6):740-753.e3. PubMed ID: 32574593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal control of gene recombination in astrocytes by transgenic expression of the tamoxifen-inducible DNA recombinase variant CreERT2.
    Hirrlinger PG; Scheller A; Braun C; Hirrlinger J; Kirchhoff F
    Glia; 2006 Jul; 54(1):11-20. PubMed ID: 16575885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Satb2
    Ambrozkiewicz MC; Bessa P; Salazar-Lázaro A; Salina V; Tarabykin V
    J Neurosci Methods; 2017 Nov; 291():113-121. PubMed ID: 28782628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tamoxifen-inducible glia-specific Cre mice for somatic mutagenesis in oligodendrocytes and Schwann cells.
    Leone DP; Genoud S; Atanasoski S; Grausenburger R; Berger P; Metzger D; Macklin WB; Chambon P; Suter U
    Mol Cell Neurosci; 2003 Apr; 22(4):430-40. PubMed ID: 12727441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of an Rtel1-CreERT2 knock-in mouse model for lineage tracing RTEL1+ stem cells during development.
    Seshadri N; Sandhu S; Wu X; Liu W; Ding H
    Transgenic Res; 2018 Dec; 27(6):571-578. PubMed ID: 30196476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wt1 and epicardial fate mapping.
    Rudat C; Kispert A
    Circ Res; 2012 Jul; 111(2):165-9. PubMed ID: 22693350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of Cre-transgenic mice using Dlx1/Dlx2 enhancers and their characterization in GABAergic interneurons.
    Potter GB; Petryniak MA; Shevchenko E; McKinsey GL; Ekker M; Rubenstein JL
    Mol Cell Neurosci; 2009 Feb; 40(2):167-86. PubMed ID: 19026749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mef2c-F10N enhancer driven β-galactosidase (LacZ) and Cre recombinase mice facilitate analyses of gene function and lineage fate in neural crest cells.
    Aoto K; Sandell LL; Butler Tjaden NE; Yuen KC; Watt KE; Black BL; Durnin M; Trainor PA
    Dev Biol; 2015 Jun; 402(1):3-16. PubMed ID: 25794678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cre fate mapping reveals lineage specific defects in neuronal migration with loss of Pitx2 function in the developing mouse hypothalamus and subthalamic nucleus.
    Skidmore JM; Cramer JD; Martin JF; Martin DM
    Mol Cell Neurosci; 2008 Apr; 37(4):696-707. PubMed ID: 18206388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating Tissue-Specific Recombination in a Pdgfrα-CreERT2 Transgenic Mouse Line.
    O'Rourke M; Cullen CL; Auderset L; Pitman KA; Achatz D; Gasperini R; Young KM
    PLoS One; 2016; 11(9):e0162858. PubMed ID: 27626928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The transcription factor Cux2 marks development of an A-delta sublineage of TrkA sensory neurons.
    Bachy I; Franck MC; Li L; Abdo H; Pattyn A; Ernfors P
    Dev Biol; 2011 Dec; 360(1):77-86. PubMed ID: 21945863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cre-mediated transgene activation in the developing and adult mouse brain.
    Cinato E; Mirotsou M; Sablitzky F
    Genesis; 2001 Nov; 31(3):118-25. PubMed ID: 11747202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Pax3-Cre transgene exhibits a rostrocaudal gradient of expression in the skeletal muscle lineage.
    Jarad G; Miner JH
    Genesis; 2009 Jan; 47(1):1-6. PubMed ID: 18942111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.